US Stock MarketDetailed Quotes
BGLC BioNexus Gene Lab
- 0.440
- +0.017+4.05%
Close Aug 26 16:00 ET
- 0.430
- -0.010-2.16%
Pre 09:04 ET
7.90MMarket Cap-3117P/E (TTM)
0.517High0.412Low1.16MVolume0.418Open0.423Pre Close522.95KTurnover11.32%Turnover RatioLossP/E (Static)17.97MShares3.39052wk High0.83P/B4.51MFloat Cap0.31052wk Low--Dividend TTM10.26MShs Float9.490Historical High--Div YieldTTM24.92%Amplitude0.310Historical Low0.450Avg Price1Lot Size
BioNexus Gene Lab Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -23.07%1.97M | 0.20%2.38M | -10.60%9.77M | -19.95%2.27M | -0.83%2.55M | 3.29%2.57M | -21.52%2.38M | -18.21%10.93M | -12.50%2.84M | -27.99%2.58M |
| Operating revenue | -23.07%1.97M | 0.20%2.38M | -10.60%9.77M | -19.95%2.27M | -0.83%2.55M | 3.29%2.57M | -21.52%2.38M | -18.21%10.93M | -12.50%2.84M | -27.99%2.58M |
| Cost of revenue | -24.30%1.69M | 0.42%2.02M | -12.70%8.44M | -19.75%2.01M | -3.35%2.2M | 0.27%2.23M | -24.86%2.01M | -12.85%9.67M | -9.67%2.5M | -20.62%2.28M |
| Gross profit | -15.01%288.72K | -1.05%365.03K | 5.60%1.33M | -21.42%266.56K | 18.31%354.33K | 28.69%339.71K | 3.53%368.9K | -44.46%1.26M | -28.91%339.23K | -57.77%299.5K |
| Operating expense | -95.17%29.55K | 5.85%444.06K | 153.07%3.92M | -98.09%8.8K | 690.44%2.88M | 52.24%611.91K | 30.43%419.53K | 28.00%1.55M | 67.30%461.92K | 8.37%364.71K |
| Selling and administrative expenses | -5.88%759.66K | 20.31%645.91K | 154.94%4.41M | -103.48%-16.96K | 635.90%3.08M | 77.46%807.08K | 45.87%536.87K | 35.37%1.73M | 166.84%487.86K | 9.24%418.82K |
| -General and administrative expense | -5.88%759.66K | 20.31%645.91K | 154.94%4.41M | -103.48%-16.96K | 635.90%3.08M | 77.46%807.08K | 45.87%536.87K | 35.37%1.73M | 166.84%487.86K | 9.24%418.82K |
| Other operating expenses | -274.10%-730.11K | -72.01%-201.85K | -171.10%-486.04K | 199.28%25.76K | -268.29%-199.28K | -269.29%-195.16K | -152.93%-117.34K | -169.63%-179.28K | -127.81%-25.94K | -15.50%-54.11K |
| Operating profit | 195.21%259.17K | -56.09%-79.03K | -790.73%-2.59M | 310.09%257.75K | -3,777.19%-2.53M | -97.30%-272.2K | -245.95%-50.63K | -127.58%-291.18K | -161.02%-122.69K | -117.50%-65.22K |
| Net non-operating interest income expense | -47.27%-4.48K | -90.63%-4.66K | -11.62%-13.93K | 12.16%-4.18K | -105.55%-4.26K | -31.18%-3.04K | 26.49%-2.45K | 3.81%-12.48K | -19.47%-4.76K | 3.63%-2.07K |
| Non-operating interest expense | 47.27%4.48K | 90.63%4.66K | 11.62%13.93K | -12.16%4.18K | 105.55%4.26K | 31.18%3.04K | -26.49%2.45K | -3.81%12.48K | 19.47%4.76K | -3.63%2.07K |
| Other net income (expense) | ||||||||||
| Income before tax | 192.53%254.69K | -57.68%-83.69K | -758.71%-2.61M | 298.96%253.57K | -3,664.13%-2.53M | -96.20%-275.24K | -269.22%-53.08K | -129.12%-303.66K | -164.67%-127.45K | -118.16%-67.29K |
| Income tax | 447.62%55.58K | 25.50%20.07K | -58.85%21.53K | -285.96%-54.89K | 655.57%76.42K | -886.43%-15.99K | 11.83%15.99K | -82.04%52.31K | -72.63%29.52K | -86.54%10.11K |
| Net income | 176.80%199.1K | -50.23%-103.76K | -638.57%-2.63M | 296.51%308.46K | -3,271.00%-2.61M | -86.97%-259.25K | -504.70%-69.07K | -147.36%-355.97K | -275.89%-156.97K | -126.21%-77.4K |
| Net income continuous Operations | 176.80%199.1K | -50.23%-103.76K | -638.57%-2.63M | 296.51%308.46K | -3,271.00%-2.61M | -86.97%-259.25K | -504.70%-69.07K | -147.36%-355.97K | -275.89%-156.97K | -126.21%-77.4K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 176.80%199.1K | -50.23%-103.76K | -638.57%-2.63M | 296.51%308.46K | -3,271.00%-2.61M | -86.97%-259.25K | -504.70%-69.07K | -147.36%-355.97K | -275.89%-156.97K | -126.21%-77.4K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 176.80%199.1K | -50.23%-103.76K | -638.57%-2.63M | 296.51%308.46K | -3,271.00%-2.61M | -86.97%-259.25K | -504.70%-69.07K | -147.36%-355.97K | -275.89%-156.97K | -126.21%-77.4K |
| Basic earnings per share | 162.93%0.0113 | -157.14%-0.018 | -297.83%-0.183 | 129.86%0.0096 | -2,809.03%-0.1555 | -86.17%-0.0179 | -685.28%-0.007 | -195.83%-0.046 | -2,137.34%-0.0322 | -125.83%-0.0053 |
| Diluted earnings per share | 162.93%0.0113 | -157.14%-0.018 | -297.83%-0.183 | 129.86%0.0096 | -2,809.03%-0.1555 | -86.17%-0.0179 | -685.28%-0.007 | -195.83%-0.046 | -2,137.34%-0.0322 | -125.83%-0.0053 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg